Skip to main content
Program
#ScientificSessions26
Late-Breaking Science
Daily Coverage
Industry Highlights
Journeys
Search
Article
Company
Video
Daily Coverage
Industry Highlights
Journeys
Late-Breaking Science
Photo Gallery
Enter search phrase
Search
Section: Late-Breaking Science
Home
#ScientificSessions26 Late-Breaking Science announced
Six sessions during the meeting are devoted to the presentation of the latest research results.
September 25, 2026
Home
Approaches to ischemic heart disease before, during and after hospitalization
November 13, 2025
Late-Breaking Science
Findings in heart failure late-breaking research
November 12, 2025
Home
Practice-changing trials in blood pressure control
November 12, 2025
Daily Coverage
Get Scientific Sessions OnDemand
Unlimited access begins December 2025.
November 12, 2025
Daily Coverage
Cutting-edge valve and coronary trials
November 10, 2025
Late-Breaking Science
Cardiometabolic and lifestyle interventions for AFib
November 9, 2025
Late-Breaking Science
Antithrombotic therapy in AFib care post procedures
November 9, 2025
Late-Breaking Science
Groundbreaking trials in cardiometabolic therapeutics
November 9, 2025
Daily Coverage
Get inspired at Scientific Sessions' Main Events
Don’t miss out on this year’s influential and premier Main Events introducing research and discoveries.
October 14, 2025
Home
Abstracts reveal research, results
#AHA25 is offering abstract oral sessions, poster sessions and moderated digital poster sessions.
October 14, 2025
Previews
Enrich your Scientific Sessions experience
All the tools you will need to maximize your time at #ScientificSessions26.
October 13, 2025
Late-Breaking Science
Late-Breaking Science sessions: Where breakthroughs are announced
September 29, 2025
AHA24
Advances in lipid therapeutics
Small-interfering RNA reduced Lp(a) levels, an oral disruptor of Lp(a) synthesis in the liver and selective cholesteryl ester transfer protein.
November 20, 2024
AHA24
New approaches to managing AFib
Combined linear ablation, radiofrequency ablation, metformin and aggressive risk factor management.
November 20, 2024
AHA24
Medical therapy for heart failure
Myeloperoxidase inhibitor, Sacubitril-Valsartan, standard loop diuretic and sodium zirconium cyclosilicate and spironolactone.
November 20, 2024
AHA24
Innovation in prevention
Two-drug polypills, electronic nudges, ZODIAC and pacemakers.
November 20, 2024
Late-Breaking Science
Harnessing AI for better heart health
Improving guideline-directed medical therapy, comparing wearable versus implanted sensors, boosting echocardiogram performance and automating echocardiographic interpretation.
November 19, 2024
Next Page
